EUVIMEDOpdag EUVIMED
Crossref

Uncovering novel therapeutic targets for premature ejaculation from gut microbiota: A prospective high‐throughput sequencing study

Guangdong Hou iD, Geng Zhang iD, Yu Zheng iD, Siyan Zhang iD, Massimo Federici iD, Ping Meng iD, Fuli Wang iD, Bo Zhang iD, Emmanuele A Jannini iD, Jianlin Yuan iD

Andrology · 2026

DOI: 10.1111/andr.70099 ↗

At a glance

Journal article in Andrology, 2026. Written by Guangdong Hou and 9 co-authors. Institution: Department of Urology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China. Major MEDLINE topics: Premature Ejaculation, Benzylamines, Gastrointestinal Microbiome, Naphthalenes. Cited 3 times so far (Crossref); 53 references. Funded by: National Natural Science Foundation of China, Natural Science Basic Research Program of Shaanxi Province, Rapid Response Program Project of the Fourth Military Medical University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Despite being the only approved oral therapy for premature ejaculation (PE), dapoxetine faces high discontinuation rates because of its suboptimal efficacy. Given that the role of gut microbiota in PE treatment has remained unexplored, we aim to investigate gut microbiota that may reflect the efficacy of dapoxetine.

Methods

Clinical data and fecal samples were collected from patients with lifelong PE before treatment. Gut microbiota was profiled via 16S rDNA sequencing, and differential microbiota between effective and ineffective groups were identified with the LEfSe method. To explore potential links between gut dysbiosis and efficacy, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway functional predictions were performed with the PICRUSt2 method. Efficacy was assessed using the Clinical Global Impression of Change (CGIC) scale, with scores ≥1 defined as the effective group.

Results

In the effective group, Erysipelotrichaceae_UCG_003, Parabacteroides_distasonis , and Prevotella_7_unclassified were significantly more prevalent, while Collinsella aerofaciens was less abundant. Their abundance was significantly correlated with CGIC scores, with correlation coefficients of 0.331, 0.250, 0.288, and ‒0.345, respectively. The discriminatory abilities of the four differential microbiota were 0.654, 0.669, 0.701, and 0.615, respectively. Incorporating them significantly improved the accuracy of the model predicting efficacy (0.796 vs. 0.738), which further suggests that modulating microbiota could be a novel strategy for PE treatment. The predicted gene abundance in the arachidonic acid metabolism pathway was significantly elevated in the effective group, indicating that dapoxetine's mechanism may also involve modulating this pathway.

Conclusions

This study identified gut microbiota associated with the efficacy of dapoxetine for the first time. Targeted modulation of specific gut microbiota may provide a novel strategy for PE treatment.

Subjects

MeSH terms (MEDLINE)

Premature EjaculationBenzylaminesGastrointestinal MicrobiomeNaphthalenesHumansMaleAdultProspective StudiesHigh-Throughput Nucleotide SequencingFecesDysbiosis

Author keywords

dapoxetinegut microbiotahigh‐throughput sequencingpremature ejaculation

Substances

dapoxetineBenzylaminesNaphthalenes

Authors and institutions

  • Department of Urology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
  • Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Department of Nephrology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Department of Nuclear Medicine, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
  • Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

ORCID profiles: Guangdong Hou, Geng Zhang, Yu Zheng, Siyan Zhang, Massimo Federici, Ping Meng, Fuli Wang, Bo Zhang, Emmanuele A Jannini, Jianlin Yuan

Funding

  • National Natural Science Foundation of China
  • Natural Science Basic Research Program of Shaanxi Province
  • Rapid Response Program Project of the Fourth Military Medical University

Cite

APA

Hou, G., Zhang, G., Zheng, Y., Zhang, S., Federici, M., Meng, P., Wang, F., Zhang, B., Jannini, E. A., & Yuan, J. (2026). Uncovering novel therapeutic targets for premature ejaculation from gut microbiota: A prospective high‐throughput sequencing study. Andrology. https://doi.org/10.1111/andr.70099

Vancouver

Hou G, Zhang G, Zheng Y, Zhang S, Federici M, Meng P, et al. Uncovering novel therapeutic targets for premature ejaculation from gut microbiota: A prospective high‐throughput sequencing study. Andrology. 2026. doi:10.1111/andr.70099

BibTeX
@article{Hou2026,
  author = {Hou, Guangdong and Zhang, Geng and Zheng, Yu and Zhang, Siyan and Federici, Massimo and Meng, Ping and Wang, Fuli and Zhang, Bo and Jannini, Emmanuele A and Yuan, Jianlin},
  title = {Uncovering novel therapeutic targets for premature ejaculation from gut microbiota: A prospective high‐throughput sequencing study},
  journal = {Andrology},
  year = {2026},
  doi = {10.1111/andr.70099}
}
Start for free →